Table 2

SSRI versus H2A/PPI fracture event rates, stratified by follow-up time

PeriodDrugNumber contributingNumber of eventsTotal person time (years)Rate per 1000 pr-years95% CI
Panel A†
 0–180 daysSSRI110 9577239 511.811.81.4 to 2.3
H2A/PPI112 6603935 009.821.10.9 to 1.4
 181–360 daysSSRI45 8234016 201.112.51.8 to 3.4
H2A/PPI27 325109008.761.10.7 to 1.6
 0–1 yearSSRI110 95711255 712.932.01.7 to 2.4
H2A/PPI112 6604944 018.581.10.9 to 1.4
 1–2 yearsSSRI23 4233713 812.442.71.9 to 3.7
H2A/PPI123 712127268.161.70.9 to 3.0
 2–3 yearsSSRI7925104929.882.01.1 to 3.8
H2A/PPI418942696.201.30.6 to 2.8
 3–4 yearsSSRI315362184.022.81.2 to 6.1
H2A/PPI177831227.032.30.9 to 5.5
 4–5 yearsSSRI13850840.600N/A
H2A/PPI7981483.061.80.3 to 12.7
 0–5 yearsSSRI110 95716577 479.872.11.8 to 2.5
H2A/PPI112 6606855 693.031.21.0 to 1.5
Panel B‡
 0–180 daysSSRI110 9578148 805.321.71.3 to 2.1
H2A/PPI112 6606149 906.191.21.0 to 1.5
 181–360 daysSSRI88 1266138 663.231.61.2 to 2.0
H2A/PPI90 5823839 868.691.00.7 to 1.2
 0–1 yearSSRI110 95714287 468.541.61.4 to 1.9
H2A/PPI112 6609989 774.881.10.9 to 1.3
 1–2 yearsSSRI68 9609552 368.981.81.5 to 2.2
H2A/PPI71 5207355 187.091.31.1 to 1.6
 2–3 yearsSSRI39 7045029 756.541.71.3 to 2.2
H2A/PPI42 4533432 475.371.10.8 to 1.4
 3–4 yearsSSRI23 1352817 633.261.61.1 to 2.3
H2A/PPI25 3752719 408.851.41.0 to 1.9
 4–5 yearsSSRI12 996158972.101.71.0 to 2.8
H2A/PPI14 5772310 271.052.31.5 to 3.4
 0–5 yearsSSRI110 957330196 199.431.71.5 to 1.9
H2A/PPI112 660257207 117.241.21.1 to 1.4
  • Number contributing and number of events rounded to integers.

  • †Women, aged 40–64, as-treated analysis, 180-day lag, 180-day induction period.

  • ‡Women, aged 40–64, first-treatment-carried-forward analysis, 180-day lag period.

  • H2A, H2 antagonist; PPI, proton-pump inhibitor; SSRI, selective serotonin reuptake inhibitor.